AI assistant
Merck & Co., Inc. — Director's Dealing 2023
May 5, 2023
284_dirs_2023-05-04_18b2fca2-6628-4621-9891-e84e6c61edbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-05-02
Reporting Person: Chattopadhyay Sanat (Exe V-P & Pres. MMD)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-02 | Stock Option (Right to Buy) | $117.89 | A | 45643 | Acquired | 2033-05-01 | Common Stock (45643) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
| Common Stock | 37873 | Indirect |
| Common Stock | 45608 | Indirect |
| Common Stock | 46995 | Indirect |
Footnotes
F1: The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2021 Grantor Retained Annuity Trust.
F2: The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2022 Grantor Retained Annuity Trust.
F3: The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2023 Grantor Retained Annuity Trust.
F4: The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.